Howe & Rusling Inc Chemo Centryx, Inc. Transaction History

Howe & Rusling Inc

  • $1.16 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$22.17 - $51.8 $487 - $1,139
22 Added 56.41%
61 $3,000
Q2 2022

Aug 15, 2022
BUY
$15.36 - $27.51 $291 - $522
19 Added 95.0%
39 $1,000
Q1 2022

May 10, 2022
SELL
$22.22 - $39.12 $133 - $234
-6 Reduced 23.08%
20 $1,000
Q4 2021

Feb 14, 2022
BUY
$18.38 - $40.5 $477 - $1,053
26 New
26 $1,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Howe & Rusling Inc Portfolio

Follow Howe & Rusling Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email